The outlook for a bill to reauthorize anti-pandemic and other health emergency programs looks good as lawmakers seek to clear unfinished health business from the last Congress.
The House on Tuesday passed a bill (H.R. 269), 401-17, to renew $7 billion in emergency pandemic-prevention programs, modify the regulatory framework for nonprescription drugs, and establish user fees for drugmakers. The legislation is a new version of a bill (
For more stories, analysis and expertiseOR Request Trial